CN Stock MarketDetailed Quotes

002901 Double Medical Technology Inc.

Watchlist
  • 31.39
  • +0.61+1.98%
Market Closed Dec 20 15:00 CST
13.00BMarket Cap64.59P/E (TTM)

Double Medical Technology Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-5.85%1.01B
-5.69%993.83M
6.37%975.72M
23.69%1.23B
66.75%1.07B
37.39%1.05B
28.63%917.32M
142.00%992.67M
83.35%644.57M
103.24%766.98M
Transactional financial assets
-46.85%251.2M
7.95%394.36M
61.38%607.73M
20.78%433.2M
-32.13%472.61M
-43.77%365.32M
-51.60%376.58M
-53.40%358.67M
33.32%696.35M
6.70%649.65M
Notes receivable and accounts receivable
-9.95%265.37M
-20.14%267.84M
-32.68%242.67M
-25.40%242.41M
-40.23%294.69M
-33.51%335.4M
-31.73%360.46M
-29.04%324.97M
27.69%493.04M
37.31%504.42M
-Notes receivable
--200K
--400K
--200K
----
----
----
----
-98.17%252.3K
-76.28%252.3K
----
-Accounts receivable
-10.02%265.17M
-20.26%267.44M
-32.73%242.47M
-25.35%242.41M
-40.20%294.69M
-33.51%335.4M
-30.34%360.46M
-26.90%324.71M
27.98%492.79M
38.15%504.42M
Other receivables (including interest and dividends)
-1.03%12.01M
17.11%11.76M
12.48%12.77M
19.47%10.46M
52.88%12.14M
14.80%10.04M
0.56%11.35M
-10.56%8.75M
-21.43%7.94M
9.28%8.75M
-Other receivable
----
17.11%11.76M
----
----
----
14.80%10.04M
----
-10.56%8.75M
----
9.28%8.75M
Contractual assets
--108.3K
--108.3K
--108.3K
--108.3K
----
----
----
----
----
----
Advance payment
0.22%55.24M
-31.93%41.61M
-23.06%37.36M
-45.99%22.01M
14.86%55.12M
41.63%61.13M
11.65%48.55M
34.36%40.74M
34.73%47.99M
-1.58%43.16M
Inventories
11.06%1.27B
11.35%1.2B
18.84%1.2B
20.85%1.19B
27.53%1.14B
36.84%1.08B
42.02%1.01B
47.33%987.35M
27.23%896.68M
35.49%789.83M
Other current assets
-41.63%16.07M
-11.20%20.37M
55.93%16.57M
99.67%26.05M
518.45%27.54M
807.50%22.94M
-76.76%10.63M
-72.21%13.05M
-94.22%4.45M
-97.63%2.53M
Total current assets
-6.45%2.88B
0.13%2.93B
13.10%3.09B
15.74%3.16B
10.37%3.08B
5.93%2.93B
-3.41%2.73B
13.82%2.73B
33.70%2.79B
32.00%2.77B
Non Current assets
Long-term equity investment
----
----
----
----
----
----
----
----
----
6.66%1.37M
Fixed assets
----
33.94%1.07B
----
----
----
17.93%796.95M
----
18.89%745.25M
----
17.11%675.79M
Constru in process
----
-68.29%52.14M
----
----
----
103.07%164.45M
----
119.35%113.1M
----
89.05%80.98M
Intangible assets
-7.76%127.63M
-7.13%130.69M
-6.99%133.88M
-4.36%136.92M
-2.53%138.36M
-2.24%140.73M
-1.64%143.94M
-3.66%143.16M
-7.05%141.95M
20.04%143.95M
Goodwill
-0.90%67.91M
-1.61%67.62M
-1.47%67.91M
-1.24%68.27M
-1.73%68.53M
-0.71%68.72M
-0.10%68.92M
-0.79%69.13M
-3.69%69.74M
301.30%69.21M
Long deferred expense
3.20%202.54M
7.30%203.32M
34.33%198.27M
80.17%197.49M
80.65%196.26M
98.75%189.49M
97.64%147.6M
91.39%109.61M
5,747.80%108.64M
4,960.82%95.34M
Deferred tax assets
88.27%11.37M
102.67%10.76M
7.48%8.79M
26.78%8.93M
-32.61%6.04M
-43.65%5.31M
-9.14%8.17M
-14.77%7.04M
28.73%8.96M
40.41%9.42M
Usufruct assets
-21.70%14.61M
-13.80%15.83M
-5.67%17.17M
-3.69%18.61M
-8.93%18.66M
-8.76%18.36M
-1.62%18.2M
-5.00%19.32M
312.54%20.49M
343.93%20.13M
Other non current assets
42.74%2.14M
31.76%1.93M
31.81%1.93M
-58.81%1.93M
-18.33%1.5M
-15.53%1.46M
37.48%1.46M
420.97%4.69M
-13.54%1.84M
38.50%1.73M
Total non current assets
11.02%1.58B
11.86%1.55B
18.56%1.53B
22.55%1.48B
22.96%1.42B
26.19%1.39B
27.00%1.29B
23.01%1.21B
28.64%1.16B
42.09%1.1B
Total assets
-0.93%4.46B
3.90%4.48B
14.85%4.62B
17.83%4.64B
14.06%4.5B
11.69%4.31B
4.62%4.02B
16.50%3.94B
32.17%3.95B
34.72%3.86B
Liabilities
Current liabilities
Short term loan
-23.41%72.05M
159.76%122.09M
1,064.44%291.11M
--316.13M
--94.07M
--47M
--25M
----
----
----
Transactional financial liabilities
----
----
----
----
----
----
----
----
----
--88.94K
Notes payable and accounts payable
-19.62%257.67M
-8.56%290.14M
-8.76%289.63M
-18.45%281.64M
-8.59%320.56M
-10.26%317.3M
11.54%317.44M
16.56%345.36M
33.69%350.68M
54.91%353.57M
-Accounts payable
-19.62%257.67M
-8.56%290.14M
-8.76%289.63M
-18.45%281.64M
-8.59%320.56M
-10.26%317.3M
11.54%317.44M
16.56%345.36M
33.69%350.68M
54.91%353.57M
Contract liabilities
-10.51%131.81M
0.74%138.2M
58.88%156.14M
25.54%171.94M
146.89%147.29M
125.44%137.18M
111.40%98.28M
134.20%136.96M
34.60%59.66M
31.23%60.85M
Salaries payable
24.99%107.55M
22.25%85.14M
15.93%65.69M
30.38%116.32M
27.55%86.05M
26.65%69.64M
29.88%56.66M
13.21%89.22M
17.44%67.46M
17.92%54.99M
Taxs payable
155.69%33.48M
109.00%20.64M
-2.86%22.12M
-41.93%18.5M
-66.57%13.09M
-75.45%9.88M
-37.37%22.77M
-67.87%31.85M
0.08%39.17M
-13.27%40.23M
Other payable (including interest and dividends)
32.34%235.85M
66.70%266.24M
100.88%221.32M
144.14%216.72M
115.36%178.22M
8.03%159.72M
-28.33%110.18M
-49.73%88.77M
-53.33%82.75M
-49.63%147.85M
-Dividend payable
----
--38.86M
----
--17.15M
----
----
----
----
----
----
-Other payable
----
42.37%227.38M
----
----
----
8.03%159.72M
----
-49.73%88.77M
----
3.49%147.85M
Non current liabilities due within one year
-65.19%59.19M
-52.37%56.38M
43.82%10.04M
44.51%11.16M
2,728.11%170.06M
1,973.34%118.36M
54.07%6.98M
53.29%7.72M
161.01%6.01M
134.10%5.71M
Other current liabilities
-17.43%15.4M
-3.16%16.77M
49.17%19M
27.50%21.33M
143.57%18.65M
121.71%17.32M
114.35%12.74M
124.86%16.73M
32.02%7.65M
27.88%7.81M
Total current liabilities
-11.19%913M
13.60%995.6M
65.38%1.08B
61.00%1.15B
67.59%1.03B
30.59%876.4M
13.00%650.05M
-0.72%716.6M
4.20%613.4M
0.21%671.09M
Current liabilities
Long term loan
15.56%232.48M
21.51%221.89M
94.02%257.62M
444.88%261.32M
301.95%201.18M
498.12%182.61M
--132.78M
--47.96M
--50.05M
--30.53M
Deferred tax liabilities
-38.95%2.37M
-30.53%1.76M
-45.14%2.38M
-38.53%3.08M
-42.65%3.87M
-67.06%2.54M
-34.19%4.33M
-33.90%5.01M
-13.47%6.76M
2,546.09%7.71M
Long term deferred income
-3.12%46.67M
3.41%48.79M
-7.35%47.32M
2.98%50.13M
9.03%48.18M
8.32%47.18M
10.96%51.07M
0.35%48.68M
-9.23%44.19M
-14.87%43.55M
Lease liabilities
-32.50%7.93M
-32.20%8M
-28.13%9.04M
-15.65%10.88M
-13.80%11.74M
-17.17%11.81M
1.29%12.58M
-5.22%12.9M
863.18%13.62M
1,228.95%14.25M
Total non current liabilities
9.24%289.44M
14.88%280.45M
57.58%316.35M
184.09%325.41M
131.18%264.97M
154.19%244.13M
208.74%200.76M
64.36%114.54M
86.64%114.62M
71.43%96.05M
Total liabilities
-7.00%1.2B
13.88%1.28B
63.54%1.39B
77.96%1.48B
77.60%1.29B
46.07%1.12B
32.88%850.81M
5.01%831.15M
11.99%728.02M
5.71%767.14M
Shareholders equity
Paid-in capital
0.00%414.02M
0.00%414.02M
0.00%414.02M
0.00%414.02M
-0.75%414.02M
-0.75%414.02M
-0.75%414.02M
2.19%414.02M
2.96%417.14M
2.96%417.14M
Capital reserve funds
-0.49%1.1B
-0.14%1.1B
-0.14%1.1B
0.00%1.1B
-6.27%1.1B
0.65%1.1B
1.81%1.1B
85.42%1.1B
109.62%1.18B
99.84%1.09B
Surplus reserve funds
0.01%271.04M
0.01%271.04M
0.00%271.04M
0.00%271.04M
-0.01%271.02M
-0.01%271.02M
0.00%271.04M
0.00%271.04M
33.45%271.04M
33.45%271.04M
Retained profit
7.42%1.41B
0.01%1.31B
4.87%1.34B
4.85%1.28B
-1.71%1.31B
0.42%1.31B
-11.73%1.28B
-8.75%1.22B
13.19%1.34B
24.84%1.3B
Less:Treasury stock
--25.31M
----
----
----
----
----
----
----
-14.63%76.65M
-14.63%76.65M
Other composite income
-39.06%-5.24M
-51.40%-5.16M
-30.58%-4.62M
-4.88%-4.25M
15.33%-3.77M
-23.36%-3.41M
-246.47%-3.53M
-143.83%-4.05M
-53.46%-4.45M
-8.00%-2.76M
Shareholders equity without minority interests
2.11%3.16B
-0.10%3.09B
1.94%3.12B
1.96%3.06B
-0.72%3.1B
2.84%3.09B
-2.11%3.06B
19.39%3B
38.18%3.12B
42.65%3.01B
Minority interests
-14.98%95.2M
15.75%116.22M
-2.61%109.21M
-4.21%102.16M
12.47%111.98M
14.49%100.41M
41.33%112.14M
40.50%106.65M
26.57%99.56M
166.34%87.7M
Total shareholder equity
1.52%3.26B
0.40%3.21B
1.78%3.23B
1.75%3.16B
-0.31%3.21B
3.17%3.19B
-1.03%3.17B
20.01%3.11B
37.79%3.22B
44.55%3.1B
Total liabilityies and equity
-0.93%4.46B
3.90%4.48B
14.85%4.62B
17.83%4.64B
14.06%4.5B
11.69%4.31B
4.62%4.02B
16.50%3.94B
32.17%3.95B
34.72%3.86B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -5.85%1.01B-5.69%993.83M6.37%975.72M23.69%1.23B66.75%1.07B37.39%1.05B28.63%917.32M142.00%992.67M83.35%644.57M103.24%766.98M
Transactional financial assets -46.85%251.2M7.95%394.36M61.38%607.73M20.78%433.2M-32.13%472.61M-43.77%365.32M-51.60%376.58M-53.40%358.67M33.32%696.35M6.70%649.65M
Notes receivable and accounts receivable -9.95%265.37M-20.14%267.84M-32.68%242.67M-25.40%242.41M-40.23%294.69M-33.51%335.4M-31.73%360.46M-29.04%324.97M27.69%493.04M37.31%504.42M
-Notes receivable --200K--400K--200K-----------------98.17%252.3K-76.28%252.3K----
-Accounts receivable -10.02%265.17M-20.26%267.44M-32.73%242.47M-25.35%242.41M-40.20%294.69M-33.51%335.4M-30.34%360.46M-26.90%324.71M27.98%492.79M38.15%504.42M
Other receivables (including interest and dividends) -1.03%12.01M17.11%11.76M12.48%12.77M19.47%10.46M52.88%12.14M14.80%10.04M0.56%11.35M-10.56%8.75M-21.43%7.94M9.28%8.75M
-Other receivable ----17.11%11.76M------------14.80%10.04M-----10.56%8.75M----9.28%8.75M
Contractual assets --108.3K--108.3K--108.3K--108.3K------------------------
Advance payment 0.22%55.24M-31.93%41.61M-23.06%37.36M-45.99%22.01M14.86%55.12M41.63%61.13M11.65%48.55M34.36%40.74M34.73%47.99M-1.58%43.16M
Inventories 11.06%1.27B11.35%1.2B18.84%1.2B20.85%1.19B27.53%1.14B36.84%1.08B42.02%1.01B47.33%987.35M27.23%896.68M35.49%789.83M
Other current assets -41.63%16.07M-11.20%20.37M55.93%16.57M99.67%26.05M518.45%27.54M807.50%22.94M-76.76%10.63M-72.21%13.05M-94.22%4.45M-97.63%2.53M
Total current assets -6.45%2.88B0.13%2.93B13.10%3.09B15.74%3.16B10.37%3.08B5.93%2.93B-3.41%2.73B13.82%2.73B33.70%2.79B32.00%2.77B
Non Current assets
Long-term equity investment ------------------------------------6.66%1.37M
Fixed assets ----33.94%1.07B------------17.93%796.95M----18.89%745.25M----17.11%675.79M
Constru in process -----68.29%52.14M------------103.07%164.45M----119.35%113.1M----89.05%80.98M
Intangible assets -7.76%127.63M-7.13%130.69M-6.99%133.88M-4.36%136.92M-2.53%138.36M-2.24%140.73M-1.64%143.94M-3.66%143.16M-7.05%141.95M20.04%143.95M
Goodwill -0.90%67.91M-1.61%67.62M-1.47%67.91M-1.24%68.27M-1.73%68.53M-0.71%68.72M-0.10%68.92M-0.79%69.13M-3.69%69.74M301.30%69.21M
Long deferred expense 3.20%202.54M7.30%203.32M34.33%198.27M80.17%197.49M80.65%196.26M98.75%189.49M97.64%147.6M91.39%109.61M5,747.80%108.64M4,960.82%95.34M
Deferred tax assets 88.27%11.37M102.67%10.76M7.48%8.79M26.78%8.93M-32.61%6.04M-43.65%5.31M-9.14%8.17M-14.77%7.04M28.73%8.96M40.41%9.42M
Usufruct assets -21.70%14.61M-13.80%15.83M-5.67%17.17M-3.69%18.61M-8.93%18.66M-8.76%18.36M-1.62%18.2M-5.00%19.32M312.54%20.49M343.93%20.13M
Other non current assets 42.74%2.14M31.76%1.93M31.81%1.93M-58.81%1.93M-18.33%1.5M-15.53%1.46M37.48%1.46M420.97%4.69M-13.54%1.84M38.50%1.73M
Total non current assets 11.02%1.58B11.86%1.55B18.56%1.53B22.55%1.48B22.96%1.42B26.19%1.39B27.00%1.29B23.01%1.21B28.64%1.16B42.09%1.1B
Total assets -0.93%4.46B3.90%4.48B14.85%4.62B17.83%4.64B14.06%4.5B11.69%4.31B4.62%4.02B16.50%3.94B32.17%3.95B34.72%3.86B
Liabilities
Current liabilities
Short term loan -23.41%72.05M159.76%122.09M1,064.44%291.11M--316.13M--94.07M--47M--25M------------
Transactional financial liabilities --------------------------------------88.94K
Notes payable and accounts payable -19.62%257.67M-8.56%290.14M-8.76%289.63M-18.45%281.64M-8.59%320.56M-10.26%317.3M11.54%317.44M16.56%345.36M33.69%350.68M54.91%353.57M
-Accounts payable -19.62%257.67M-8.56%290.14M-8.76%289.63M-18.45%281.64M-8.59%320.56M-10.26%317.3M11.54%317.44M16.56%345.36M33.69%350.68M54.91%353.57M
Contract liabilities -10.51%131.81M0.74%138.2M58.88%156.14M25.54%171.94M146.89%147.29M125.44%137.18M111.40%98.28M134.20%136.96M34.60%59.66M31.23%60.85M
Salaries payable 24.99%107.55M22.25%85.14M15.93%65.69M30.38%116.32M27.55%86.05M26.65%69.64M29.88%56.66M13.21%89.22M17.44%67.46M17.92%54.99M
Taxs payable 155.69%33.48M109.00%20.64M-2.86%22.12M-41.93%18.5M-66.57%13.09M-75.45%9.88M-37.37%22.77M-67.87%31.85M0.08%39.17M-13.27%40.23M
Other payable (including interest and dividends) 32.34%235.85M66.70%266.24M100.88%221.32M144.14%216.72M115.36%178.22M8.03%159.72M-28.33%110.18M-49.73%88.77M-53.33%82.75M-49.63%147.85M
-Dividend payable ------38.86M------17.15M------------------------
-Other payable ----42.37%227.38M------------8.03%159.72M-----49.73%88.77M----3.49%147.85M
Non current liabilities due within one year -65.19%59.19M-52.37%56.38M43.82%10.04M44.51%11.16M2,728.11%170.06M1,973.34%118.36M54.07%6.98M53.29%7.72M161.01%6.01M134.10%5.71M
Other current liabilities -17.43%15.4M-3.16%16.77M49.17%19M27.50%21.33M143.57%18.65M121.71%17.32M114.35%12.74M124.86%16.73M32.02%7.65M27.88%7.81M
Total current liabilities -11.19%913M13.60%995.6M65.38%1.08B61.00%1.15B67.59%1.03B30.59%876.4M13.00%650.05M-0.72%716.6M4.20%613.4M0.21%671.09M
Current liabilities
Long term loan 15.56%232.48M21.51%221.89M94.02%257.62M444.88%261.32M301.95%201.18M498.12%182.61M--132.78M--47.96M--50.05M--30.53M
Deferred tax liabilities -38.95%2.37M-30.53%1.76M-45.14%2.38M-38.53%3.08M-42.65%3.87M-67.06%2.54M-34.19%4.33M-33.90%5.01M-13.47%6.76M2,546.09%7.71M
Long term deferred income -3.12%46.67M3.41%48.79M-7.35%47.32M2.98%50.13M9.03%48.18M8.32%47.18M10.96%51.07M0.35%48.68M-9.23%44.19M-14.87%43.55M
Lease liabilities -32.50%7.93M-32.20%8M-28.13%9.04M-15.65%10.88M-13.80%11.74M-17.17%11.81M1.29%12.58M-5.22%12.9M863.18%13.62M1,228.95%14.25M
Total non current liabilities 9.24%289.44M14.88%280.45M57.58%316.35M184.09%325.41M131.18%264.97M154.19%244.13M208.74%200.76M64.36%114.54M86.64%114.62M71.43%96.05M
Total liabilities -7.00%1.2B13.88%1.28B63.54%1.39B77.96%1.48B77.60%1.29B46.07%1.12B32.88%850.81M5.01%831.15M11.99%728.02M5.71%767.14M
Shareholders equity
Paid-in capital 0.00%414.02M0.00%414.02M0.00%414.02M0.00%414.02M-0.75%414.02M-0.75%414.02M-0.75%414.02M2.19%414.02M2.96%417.14M2.96%417.14M
Capital reserve funds -0.49%1.1B-0.14%1.1B-0.14%1.1B0.00%1.1B-6.27%1.1B0.65%1.1B1.81%1.1B85.42%1.1B109.62%1.18B99.84%1.09B
Surplus reserve funds 0.01%271.04M0.01%271.04M0.00%271.04M0.00%271.04M-0.01%271.02M-0.01%271.02M0.00%271.04M0.00%271.04M33.45%271.04M33.45%271.04M
Retained profit 7.42%1.41B0.01%1.31B4.87%1.34B4.85%1.28B-1.71%1.31B0.42%1.31B-11.73%1.28B-8.75%1.22B13.19%1.34B24.84%1.3B
Less:Treasury stock --25.31M-----------------------------14.63%76.65M-14.63%76.65M
Other composite income -39.06%-5.24M-51.40%-5.16M-30.58%-4.62M-4.88%-4.25M15.33%-3.77M-23.36%-3.41M-246.47%-3.53M-143.83%-4.05M-53.46%-4.45M-8.00%-2.76M
Shareholders equity without minority interests 2.11%3.16B-0.10%3.09B1.94%3.12B1.96%3.06B-0.72%3.1B2.84%3.09B-2.11%3.06B19.39%3B38.18%3.12B42.65%3.01B
Minority interests -14.98%95.2M15.75%116.22M-2.61%109.21M-4.21%102.16M12.47%111.98M14.49%100.41M41.33%112.14M40.50%106.65M26.57%99.56M166.34%87.7M
Total shareholder equity 1.52%3.26B0.40%3.21B1.78%3.23B1.75%3.16B-0.31%3.21B3.17%3.19B-1.03%3.17B20.01%3.11B37.79%3.22B44.55%3.1B
Total liabilityies and equity -0.93%4.46B3.90%4.48B14.85%4.62B17.83%4.64B14.06%4.5B11.69%4.31B4.62%4.02B16.50%3.94B32.17%3.95B34.72%3.86B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme 3D Printing
3D Printing
Intraday+0.96%
Medical Device Concept
Medical Device Concept
Intraday+0.57%
Health China
Health China
Intraday+0.56%